期刊文献+

高效液相色谱-质谱联用法测定人血浆中麦考酚酸的浓度 被引量:1

Determination the concentration of mycophenolic acid in human plasma by HPLC-MS
原文传递
导出
摘要 目的建立高效液相色谱-质谱联用测定人血浆中麦考酚酸浓度的方法。方法以苯巴比妥为内标,色谱柱为ZORBAX Eclipse XDB—C18(2.1mm×150mm,3.5μm),流动相为0.05%乙酸铵-乙腈(45:55),流速为0.2mL·min^-1,柱温35℃,电喷雾离子源(ESI)正负离子同时检测。结果麦考酚酸的线性范围为0.5—100.0μg·mL^-1;最低检测限分别为0.1μg·mL^-1。高、中、低3个浓度的日内标准偏差小于3%,日间标准偏差小于15%,绝对回收率均大于70%。结论本方法简便、快速、灵敏、重现性好,能有效检测人血浆中麦考酚酸的含量。 Objective To establish a HPLC -MS method for determina- tion the concentration of mycophenolic acid in human plasma. Methods Phenobarbital was used as internal standard. After precipitation, the analysis was chromatographed on a XDB - C18 (2. 1 mm ×150mm,3.5μm). An isocratic mobile phase consisted of 0. 05% ammonium acetate in water - aceto- nitrile (45:55). The flow rate was 0. 2 mL· min^-1 and column temperature was 35 ℃. ESI electrospmy ionization source in both negative and positive modes. Results The calibration curves of each drug showed a good linearity in a range of concentration between 0. 5 - 100. 0 μg·mL^-1 for sodium valproate. Intra and inter precision(RSD% ) were less than 3% and 15% , respectively. The recoveries were above 70%. Conclusion The method is simple, rapid, sensitive and stable which is suitable for determination of the concentration of mycophenolic acid in human plasma.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2013年第11期857-858,868,共3页 The Chinese Journal of Clinical Pharmacology
关键词 高效液相色谱-质谱 麦考酚酸 血药浓度 LC - MS mycophenolic acid plasma concentration
  • 相关文献

参考文献9

二级参考文献52

  • 1沈杰,焦正,郁韵秋,迟丹怡,张明,钟明康.高效液相色谱荧光检测法测定人血浆中麦考酚酸的浓度[J].中国新药与临床杂志,2005,24(1):11-13. 被引量:13
  • 2王健康,张福成,张华峰,董晓莉,苗新.吗替麦考酚酯片在男性健康志愿者体内生物等效性研究[J].解放军药学学报,2006,22(1):40-43. 被引量:7
  • 3周佩军,徐达,王祥慧,余自成,赵菊平.肾移植受者霉酚酸治疗药物监测[J].上海交通大学学报(医学版),2006,26(6):680-684. 被引量:11
  • 4宋玲,胡拥军,胡静,邓体瑛.高效液相色谱法测定人血浆中吗替麦考酚酯浓度[J].长江大学学报(自科版)(下旬),2007,4(1):96-97. 被引量:1
  • 5Yu ZC, Zhou PJ, Xu D.et al. Investigation on pharmacokinetics of myeophenolic acid in Chinese adult renal transplant patients[J]. British Journal of Clinical Pharmacology, 2006,10(11) : 1 365.
  • 6Nobuyuki S, Takayuki S. Clinical pharmacokinetics of mycophenolate mofetil in japanese renal transplant recipients: a retrospective cohort study in a single center [J ]. Biol Pharm Bull, 2006,29(10) : 2 099.
  • 7ANGSTEN G, CEDERBLAD G, MEURLING S. Reference ranges for muscle camitine concentration in children [J]. Ann Clin Biochem, 2003, 40 (4): 404-410.
  • 8CORRADO A, LODOVICA V, ANDVEA M. Clinical and biochemical aspects of carnitine deficiency and insufficiency: transport defects and inborn errors of oxidation [J]. Crit Rev Clin Lab Sci, 1992, 29 (3-4): 217-242.
  • 9FRED S. Should carnitine be added to parenteral nutrition solutions [J]. Nutr Clin Pract, 2000, 15(1): 152-154.
  • 10Atcheson B, Taylor PJ, Mudge DW, et al. Quantification of free myco phenolic acid and its glucuronide metabolite in human plasma by liquid- chromatography using mass spectrometric and ultraviolet absorbance de tection[J]. J Chromatogr B Analyt Technul Biomed Life Sci, 2004,799 (1) :157 -163.

共引文献14

同被引文献3

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部